Teknova to Report First Quarter Financial Results
Teknova, also known as Alpha Teknova, Inc. (Nasdaq: TKNO), is gearing up to share its financial results for the first quarter. As an industry leader in producing essential reagents for the life sciences sector, Teknova continues to push the boundaries of innovation. The company will officially release its first-quarter results on an upcoming Thursday.
Financial Reporting Date and Webcast Details
On a chosen Thursday, Teknova will provide insights into its financial performance for the first quarter, with the results expected right after the market closes. Along with the financial report, Teknova will host a comprehensive webcast conference call, where stakeholders can gain valuable information directly from the company’s leadership.
How to Join the Webcast
For those wishing to participate in the discussion, Teknova will offer a live webcast starting at 5 p.m. Eastern Time. This opportunity allows investors and interested parties to engage with the company’s executives. Participants can easily access the webcast through the company’s Investor Relations page.
Receiving Unique Access
If you’re interested in joining the call, registration will be necessary. Upon registering, attendees will receive a special PIN number and dial-in information, ensuring a smooth experience during the financial presentation.
About Teknova
Founded in 1996, Teknova has grown into a vital player in providing critical reagents that help drive innovations within the healthcare sector. The company specializes in tailored solutions for a range of applications in molecular diagnostics, therapeutic development, and synthetic biology. Teknova’s extensive product offerings include high-quality agar plates, microbial culture media, buffers, and other vital reagents.
Commitment to Quality and Innovation
With more than 180,000 square feet of modern facilities, Teknova employs a modular manufacturing platform designed by a skilled team dedicated to quality control and efficiency. This commitment ensures that Teknova supports customers seamlessly as they advance from research use to commercial manufacturing.
Investor and Media Relations
Teknova maintains transparent communication with its investors and the public through dedicated personnel. The Chief Financial Officer, Matt Lowell, is available for investor inquiries, emphasizing the company’s openness to stakeholder engagement. Media relations are managed by Jennifer Henry, the Senior Vice President of Marketing, who ensures accurate dissemination of information about the company’s initiatives and innovations.
Frequently Asked Questions
What are Teknova's financial reporting dates?
Teknova is set to announce its first-quarter financial results on a selected Thursday, following market closure.
How can I attend the Teknova financial webcast?
Interested individuals can access the live webcast through the Investor Relations section on Teknova's website.
What products does Teknova offer?
Teknova specializes in critical reagents, including agar plates, microbial culture media, and buffers for various applications in life sciences.
Who can I contact for investor inquiries?
Matt Lowell, the Chief Financial Officer, is your go-to contact for any investor-related questions or information.
What is Teknova's commitment towards quality?
Teknova prides itself on producing high-quality products through an efficient modular manufacturing process, ensuring reliable support in the life sciences industry.
